Genetic diversity of carbapenem-resistant Klebsiella Pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt. 2020

Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, 1st Al-Saray Street, Al-Manial, Cairo, 11559, Egypt. doaa.ghaith@kasralainy.edu.eg.

Neonatal sepsis is a great challenge for clinicians and infection control practitioners, especially in facilities with limited resources. Carbapenem-resistant Klebsiella pneumoniae (CRKP) is rapidly increasing and carriages a major threat to neonates. We aimed to examine phenotypes causing neonatal late onset sepsis (NLOS) in comparison with neonatal early onset sepsis (NEOS) with further investigations of genotypes, and genetic relatedness of CRKP in neonatal late-onset sepsis. Our study included 88 neonates diagnosed with sepsis: 58 with (NLOS) and 30 with (NEOS) from November 2015 to April 2016, at neonatal intensive care unit (NICU) of Cairo University Hospital. K. pneumoniae was the most common encountered pathogen in the NLOS group (37.9%) with a mean sepsis score of 6.39 when compared to the NEOS group (p < 0.05). In Klebsiella group, C-reactive protein and interleukin-6 levels were significantly high (p ˂ 0.001) and 56.5% of the isolates were meropenem resistant. The most prevalent carbapenemase gene was OXA-48 which was identified in 14/23 (60.8%) followed by NDM-1 which was identified in 12/23 (52.2%) as detected by multiplex PCR. Coexistence of both carbapenemases was found in 52.2% (12/23). The blaKPC, blaIMP, and blaVIM genes were not harbored in the isolates. By investigating the genetic relatedness of CRKP by pulsed-field gel electrophoresis, 23 isolates of K. pneumoniae revealed various pulsed-field gel electrophoresis (PFGE) patterns, demonstrating that the isolates were non-clonal. Awareness of the existing phenotypes and genotypes is important for proper treatment and infection control practices.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007363 Intensive Care Units, Neonatal Hospital units providing continuing surveillance and care to acutely ill newborn infants. Neonatal Intensive Care Unit,Neonatal Intensive Care Units,Newborn Intensive Care Unit,Newborn Intensive Care Units,ICU, Neonatal,Neonatal ICU,Newborn ICU,Newborn Intensive Care Units (NICU),ICU, Newborn,ICUs, Neonatal,ICUs, Newborn,Neonatal ICUs,Newborn ICUs
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004534 Egypt A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo. Arab Republic of Egypt,United Arab Republic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071074 Neonatal Sepsis Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age. Neonatal Early-Onset Sepsis,Neonatal Late-Onset Sepsis,Sepsis, Neonatal,Early-Onset Sepses, Neonatal,Early-Onset Sepsis, Neonatal,Late-Onset Sepses, Neonatal,Late-Onset Sepsis, Neonatal,Neonatal Early Onset Sepsis,Neonatal Early-Onset Sepses,Neonatal Late Onset Sepsis,Neonatal Late-Onset Sepses,Neonatal Sepses,Sepses, Neonatal,Sepses, Neonatal Early-Onset,Sepses, Neonatal Late-Onset,Sepsis, Neonatal Early-Onset,Sepsis, Neonatal Late-Onset

Related Publications

Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
March 2023, Indian journal of pediatrics,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
July 2021, Journal of tropical pediatrics,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
August 2012, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
January 2015, Infectious diseases (London, England),
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
February 2017, Korean journal of critical care medicine,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
December 2022, mSystems,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
June 2020, Infection control and hospital epidemiology,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
January 2021, Frontiers in medicine,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
January 2020, Infection and drug resistance,
Doaa M Ghaith, and Mai Mahmoud Zafer, and Halaa Mufeed Said, and Sherif Elanwary, and Salwa Elsaban, and Mohamed Hamed Al-Agamy, and Marie Fe F Bohol, and Mahmoud Mohamed Bendary, and Ahmed Al-Qahtani, and Mohammed N Al-Ahdal
November 2016, Microbial pathogenesis,
Copied contents to your clipboard!